MP30-17 MULTIPARAMETRIC MRI- AND CONTRAST ENHANCED ULTRASOUND-TARGETED BIOPSY FOR THE DETECTION OF SIGNIFICANT PROSTATE CANCER: CAN WE REPLACE SYSTEMATIC BIOPSY?

Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.